2016
DOI: 10.15252/emmm.201606609
|View full text |Cite
|
Sign up to set email alerts
|

Constitutive activation of DIA 1 ( DIAPH 1) via C‐terminal truncation causes human sensorineural hearing loss

Abstract: DIAPH1 encodes human DIA1, a formin protein that elongates unbranched actin. The c.3634+1G>T DIAPH1 mutation causes autosomal dominant nonsyndromic sensorineural hearing loss, DFNA1, characterized by progressive deafness starting in childhood. The mutation occurs near the C‐terminus of the diaphanous autoregulatory domain (DAD) of DIA1, which interacts with its N‐terminal diaphanous inhibitory domain (DID), and may engender constitutive activation of DIA1. However, the underlying pathogenesis that causes DFNA1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
99
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 60 publications
(102 citation statements)
references
References 44 publications
2
99
0
1
Order By: Relevance
“…It is therefore tempting to propose a similar scenario in this form of hearing impairment, i.e., an alteration of the apical pole of the hair cells. Consistently, transgenic mouse model of DFNA1 shows sparse and fused stereociliary bundle (Ueyama et al, 2016). …”
Section: Discussionmentioning
confidence: 60%
“…It is therefore tempting to propose a similar scenario in this form of hearing impairment, i.e., an alteration of the apical pole of the hair cells. Consistently, transgenic mouse model of DFNA1 shows sparse and fused stereociliary bundle (Ueyama et al, 2016). …”
Section: Discussionmentioning
confidence: 60%
“…Through cooperation of the two domains, formins contribute to various biological functions via regulation of actin dynamics. The physiological significance of formins is exemplified by the fact that mutations in human formins are linked to various human diseases including hearing loss (Lynch et al, 1997;Ueyama et al, 2016), nephrotic syndrome (Brown et al, 2010), cardiomyopathies (Arimura et al, 2013;Wooten et al, 2013), and intellectual disability (Law et al, 2014).…”
mentioning
confidence: 99%
“…For quantitative assessment of immunoreactive bands, ImageJ software (National Institutes of Health) was used as previously described (Ueyama et al . ). Protein expression levels were normalized to those of tubulinα, actin‐β, or GAPDH.…”
Section: Methodsmentioning
confidence: 97%
“…Immunoreactivity was detected using the enhanced chemiluminescence (ECL) detection system (Bio-Rad Laboratories, Hercules, CA, USA). For quantitative assessment of immunoreactive bands, ImageJ software (National Institutes of Health) was used as previously described (Ueyama et al 2016). Protein expression levels were normalized to those of tubulina, actin-b, or GAPDH.…”
Section: Sample Preparation and Immunoblottingmentioning
confidence: 99%